|
|
Volumn 5, Issue 2 SUPPL., 1998, Pages 33-40
|
|
The use of erythropoietin in radiation oncology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ETOPOSIDE;
FERROUS SULFATE;
HEMOGLOBIN;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
BREAST CANCER;
CANCER;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ERYTHROCYTE TRANSFUSION;
HEAD AND NECK CANCER;
HEMOGLOBIN DETERMINATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PROSTATE CANCER;
RADIATION INJURY;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
UTERINE CERVIX CANCER;
|
|
EID: 0031980077
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: 10.1177/107327489800502s07 Document Type: Review |
|
Times cited : (7)
|
|
References (27)
|